Judgment of the General Court (Fifth Chamber) of 4 July 2012.#Laboratoires CTRS v European Commission.#Medicinal products for human use — Marketing authorisation for the medicinal product Orphacol — Letter informing the applicant of the Commission’s intention to refuse authorisation — Application for a declaration of failure to act — Definition of position by the Commission — Inadmissibility — Application for annulment — Adoption of a new decision — No need to adjudicate.#Case T-12/12.

Judgment of the General Court (Fifth Chamber) of 4 July 2012.
Laboratoires CTRS v European Commission.
Medicinal products for human use — Marketing authorisation for the medicinal product Orphacol — Letter informing the applicant of the Commission’s intention to refuse authorisation — Application for a declaration of failure to act — Definition of position by the Commission — Inadmissibility — Application for annulment — Adoption of a new decision — No need to adjudicate.
Case T-12/12.

Judgment of the General Court (Fifth Chamber) of 4 July 2012.
Laboratoires CTRS v European Commission.
Medicinal products for human use — Marketing authorisation for the medicinal product Orphacol — Letter informing the applicant of the Commission’s intention to refuse authorisation — Application for a declaration of failure to act — Definition of position by the Commission — Inadmissibility — Application for annulment — Adoption of a new decision — No need to adjudicate.
Case T-12/12.

European Court Reports 2012 -00000

ECLI identifier: ECLI:EU:T:2012:343